A career in quantitative trading or research is one of the most exciting and intellectually rewarding paths in finance.

Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy for breast cancer, regardless of a patient's ESR1 mutation status. Top-line ...

Slowly but surely, the 2026 NFL Draft is approaching, so let's dive into our latest mock draft where QBs fly off the board.

EcoGraf is pleased to announce the Epanko Graphite Project Expansion Study examined the potential to expand production to support the Company's strategy of developing its commercial scale EcoGraf ...

Epanko Expansion Supports EcoGraf HFfree®Downstream Facilities Staged Expansion to 390,000 tpa to become Africa's Largest Planned Graphite Producer EcoGraf Limited is pleased to announce the Epanko ...